This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
4 Known Drug Interactions — Some May Be Serious
1 Severe3 Moderate
This herb may interact with medications you are taking. Review the interactions table below and consult your healthcare provider before use.
What is a herb–drug interaction?
A herb–drug interaction happens when a plant or supplement changes how a medication works in your body — making it stronger, weaker, or more likely to cause harm. Herbs contain active compounds that can speed up or slow down the enzymes and transporters your body uses to process drugs.
Why it matters
•St. John's Wort can make birth control, antidepressants, and blood thinners less effective.
•Garlic can increase bleeding risk with warfarin and other blood thinners (also ginkgo, ginger, and turmeric).
•Kava can amplify sedation when taken with anxiety or sleep medications (also valerian).
The risk is highest for older adults, anyone taking several medications, and people with chronic conditions.
Always tell your doctor and pharmacist about every herb and supplement you take — and check below before combining.
Berberine has similar blood sugar-lowering mechanisms to metformin. Combining them may cause excessive blood sugar reduction (hypoglycemia).
This list reflects a curated subset of documented interactions and is not exhaustive. The absence of a drug here is not proof that it is safe to combine. Always confirm with a pharmacist or healthcare provider.
Berberine works primarily by activating AMP-activated protein kinase (AMPK), an enzyme often called the "metabolic master switch." This activation improves insulin sensitivity, reduces glucose production in the liver, and enhances glucose uptake by cells. Berberine also exhibits antimicrobial activity by interfering with bacterial adhesion and growth. Additionally, it may help lower cholesterol by increasing LDL receptor expression on liver cells. These multi-target mechanisms explain berberine's wide-ranging effects on metabolic health and its comparison to pharmaceutical drugs like metformin (Evidence Level: B).
Can I take berberine with diabetes medications like metformin?
Berberine can interact with diabetes medications, potentially causing additive blood sugar-lowering effects that may lead to hypoglycemia. When combined with drugs like metformin, insulin, or sulfonylureas, berberine may enhance their glucose-lowering action, requiring dosage adjustments and careful blood glucose monitoring. If you take prescription diabetes medications, consult your healthcare provider before starting berberine supplementation. Other notable interactions include potential additive effects with blood pressure medications and certain antibiotics. Medical supervision is strongly recommended when combining berberine with any prescription medication (Evidence Level: B).
What is the recommended daily dosage for berberine?
The standard adult dosage for berberine is 500mg taken 2-3 times daily with meals, totaling 1000-1500mg per day. Taking berberine with food improves absorption and reduces gastrointestinal side effects. The supplement should be spaced throughout the day rather than taken all at once, as berberine has a relatively short half-life of approximately 4-6 hours. Starting with a lower dose and gradually increasing can help minimize digestive discomfort. Always follow product-specific recommendations and consult a healthcare provider for personalized dosing guidance (Evidence Level: B).
Is berberine safe to take during pregnancy?
Berberine is unsafe during pregnancy and should be strictly avoided. Research indicates that berberine can cross the placenta and may stimulate uterine contractions, potentially causing miscarriage or preterm labor. Berberine has also been associated with kernicterus, a serious type of brain damage in newborns, due to its effects on bilirubin metabolism. Breastfeeding women should likewise avoid berberine, as it passes into breast milk and may harm nursing infants. Women who are pregnant, planning pregnancy, or breastfeeding should not use berberine supplements (Evidence Level: B).
What are the common side effects of berberine?
The most common side effects of berberine are gastrointestinal, including stomach upset, cramping, nausea, diarrhea or constipation, and flatulence. These effects are typically mild and often improve with continued use or by taking berberine with food. Some users report headaches or temporary drops in blood pressure. Dividing the total daily dose into smaller amounts taken throughout the day can help reduce digestive discomfort. If side effects persist or worsen, discontinue use and consult a healthcare provider. Serious adverse effects are rare at recommended dosages (Evidence Level: B).
What health conditions is berberine used for?
Berberine has been used traditionally and in modern practice for several health conditions. Research supports its use for type 2 diabetes, where it may help lower blood sugar levels comparably to some pharmaceutical medications. It is also used for high cholesterol, polycystic ovary syndrome (PCOS), and metabolic syndrome. Traditional uses include treating digestive infections, diarrhea, and eye infections due to its antimicrobial properties. Some evidence suggests benefits for non-alcoholic fatty liver disease and cardiovascular health. Most research evidence is rated Level B, indicating moderate-quality scientific support for these applications.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Berberine is an isoquinoline alkaloid found in Berberis vulgaris and other plants, demonstrating wide-ranging pharmacological activities including antidiabetic, lipid-lowering, and antimicrobial effects [PMID:30637820, PMID:32335802].
Background
Berberine is a quaternary ammonium salt from the protoberberine group of isoquinoline alkaloids [PMID:27671811]. It is found in various plants, including Berberis vulgaris (barberry), Berberis aquifolium (Oregon grape), Berberis aristata (tree turmeric), Coptis chinensis (Chinese goldthread), and Hydrastis canadensis (goldenseal) [PMID:27671811, PMID:33242239].
Traditional uses
In traditional Chinese medicine, it has been used for many years to address conditions such as diarrhea and dysentery [PMID:38522318, PMID:11607041]. Barberry has various medicinal applications in the folk medicine of Iran [PMID:30637820].
Active compounds
The primary active compound is berberine, an isoquinoline alkaloid present in the roots, rhizomes, stem, and bark of B. vulgaris [PMID:30637820, PMID:33242239]. Other compounds in barberry species include anthocyanins, flavonoids, phenolic compounds, vitamins, minerals, and berbamine [PMID:31077383, PMID:24600191].
Mechanism of action
Berberine exerts effects through antioxidant, anti-inflammatory, and antimicrobial activities [PMID:35889396]. It may regulate the gastrointestinal microbiota to improve insulin resistance and lipid-lowering [PMID:33680978, PMID:41243097]. Molecular mechanisms include inducing apoptosis, activating autophagy, and inhibiting cancer cell proliferation [PMID:35889396, PMID:32735398]. In the nervous system, it may act via the Pl3K/Akt/Bcl-2, Nrf2/HO-1, and MAPK signaling pathways [PMID:29732634]. Cardiovascular effects are attributed to the blockade of K+ channels and stimulation of the Na+-Ca(2+) exchanger [PMID:11607041].
Lipid-lowering actions have been clearly demonstrated in numerous randomized clinical trials [PMID:30637820, PMID:27671811].
Evidence CCancer
Inhibits proliferation of various cancer cells and improves the efficacy and safety of chemoradiotherapies [PMID:32335802].
Evidence CCardiovascular Disease
Preliminary evidence suggests a reduction in endothelial inflammation and improvement in vascular health [PMID:27671811].
Evidence CGastrointestinal Disorders
Can inhibit toxins and bacteria, including Helicobacter pylori, and protect the intestinal epithelial barrier [PMID:32335802].
Safety & adverse effects
Berberine generally has very low toxicity in usual doses and reveals clinical benefits without major side effects [PMID:30637820, PMID:33680978]. However, some reports indicate it could induce gastrointestinal upset and ulceration, with toxicity depending on the route and duration of administration [PMID:28656087]. It has not been linked to serum aminotransferase elevations or clinically apparent liver injury [PMID:33242239].
Drug interactions
Concomitant administration of berberine with other drugs such as metformin, cyclosporine A, and digoxin may result in important interactions [PMID:36221815].
Evidence summary
The evidence for berberine's effects on glycemic control and lipid metabolism is strong, supported by systematic reviews and RCTs. Evidence for anticancer, neuroprotective, and cardiovascular effects is primarily based on reviews and animal/in vitro models.
PubMed sources
1.PMID: 30637820 (2019) — Berberine and barberry (Berberis vulgaris): A clinical review. · Phytotherapy research : PTR
2.PMID: 32335802 (2020) — Biological properties and clinical applications of berberine. · Frontiers of medicine
3.PMID: 28290706 (2017) — The metabolism of berberine and its contribution to the pharmacological effects. · Drug metabolism reviews
4.PMID: 27671811 (2016) — Berberine and Its Role in Chronic Disease. · Advances in experimental medicine and biology
5.PMID: 33680978 (2020) — Effects of Berberine on the Gastrointestinal Microbiota. · Frontiers in cellular and infection microbiology
6.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
PMID: 35889396 (2022) — Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review. · Molecules (Basel, Switzerland)
7.PMID: 38522318 (2024) — Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis. · Phytomedicine : international journal of phytotherapy and phytopharmacology
8.PMID: 33242239 (2012) — Berberine. · Alternative medicine review : a journal of clinical therapeutic
9.PMID: 25498346 (2015) — Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. · Journal of ethnopharmacology
10.PMID: 27528198 (2016) — Berberis Vulgaris and Berberine: An Update Review. · Phytotherapy research : PTR
11.PMID: 28656087 (2017) — Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review. · Iranian journal of basic medical sciences
12.PMID: 39944624 (2025) — Advance in identified targets of berberine. · Frontiers in pharmacology
13.PMID: 29732634 (2018) — Berberine: Pathways to protect neurons. · Phytotherapy research : PTR
14.PMID: 11607041 (2001) — Cardiovascular actions of berberine. · Cardiovascular drug reviews
15.PMID: 31827685 (2019) — Anti-Inflammatory and Immunomodulatory Effects of Barberry (Berberis vulgaris) and Its Main Compounds. · Oxidative medicine and cellular longevity
16.PMID: 36221815 (2022) — Pharmacokinetic of berberine, the main constituent of Berberis vulgaris L.: A comprehensive review. · Phytotherapy research : PTR
17.PMID: 41243097 (2025) — Berberine ameliorates high-fat diet-induced metabolic disorders through promoting gut Akkermansia and modulating bile acid metabolism. · Chinese medicine
18.PMID: 31077383 (2019) — Investigating functional properties of barberry species: an overview. · Journal of the science of food and agriculture
19.PMID: 32735398 (2020) — Berberine: A novel therapeutic strategy for cancer. · IUBMB life
20.PMID: 28656085 (2017) — Berberis vulgaris for cardiovascular disorders: a scoping literature review. · Iranian journal of basic medical sciences
21.PMID: 24600191 (2014) — Phytochemistry and pharmacology of berberis species. · Pharmacognosy reviews
22.PMID: 35668943 (2022) — Berberine: A Promising Treatment for Neurodegenerative Diseases. · Frontiers in pharmacology
23.PMID: 36186093 (2022) — Neuroprotective Effect of Root Extracts of Berberis Vulgaris (Barberry) on Oxidative Stress on SH-SY5Y Cells. · Journal of pharmacopuncture
24.PMID: 33340158 (2021) — A review on pain-relieving activity of berberine. · Phytotherapy research : PTR
25.PMID: 27757035 (2016) — Role of berberine in Alzheimer's disease. · Neuropsychiatric disease and treatment
26.PMID: 31902359 (2020) — New Development of Novel Berberine Derivatives against Bacteria. · Mini reviews in medicinal chemistry
27.PMID: 32507431 (2020) — The effect of barberry (Berberis vulgaris L.) on glycemic indices: A systematic review and meta-analysis of randomized controlled trials. · Complementary therapies in medicine
28.PMID: 32564751 (2020) — Berberine Administration in Treatment of Colitis: A Review. · Current drug targets
29.PMID: 40319817 (2025) — Berberine alleviates tendinopathy by suppressing the cGAS-STING pathway and Relieving ferroptosis. · Biochemical and biophysical research communications